Financial Performance - The company reported revenue of HKD 109.7 million for the fiscal year ending June 30, 2021, an increase of approximately 51.7% compared to HKD 72.3 million in the previous fiscal year[7]. - Profit for the year was approximately HKD 61 million, representing an increase of about 98.7% from HKD 30.7 million in the prior fiscal year[7]. - The group's revenue for the year was approximately HKD 109,700,000, an increase of about 51.7% compared to HKD 72,300,000 for the year ended June 30, 2020[23]. - Profit attributable to equity holders for the year was approximately HKD 61,000,000, representing an increase of about 98.7% from approximately HKD 30,700,000 for the year ended June 30, 2020[30]. - Revenue from healthcare staffing solutions was approximately HKD 92,100,000, an increase of about HKD 25,200,000 or 37.7% from approximately HKD 66,900,000 for the year ended June 30, 2020[23]. - Revenue from outreach case assessment services grew approximately 242.9% to about HKD 16,800,000, driven by increased demand for medical and health assessment services[23]. - The net profit margin increased from approximately 42.4% to about 55.6% for the year[30]. Business Expansion and Strategy - The company aims to expand its operations in the Greater Bay Area, which has a population of over 86 million, to meet the growing demand for quality healthcare services[11]. - The company has established a solid foundation for expansion by purchasing properties in Hong Kong, facilitating future commitments in the Greater Bay Area[11]. - The group anticipates continued growth in its core business due to rising demand for healthcare staffing solutions amid an aging population and ongoing hospital development plans[20]. - The company is committed to sustainable and diversified business development as a priority for future growth[11]. Community Engagement and Health Initiatives - The company is actively involved in community health initiatives, including providing COVID-19 testing services and operating vaccination centers[7]. - The company emphasizes the importance of preventive care and has been a pioneer in community health during the COVID-19 pandemic[7]. - The company participated in various social activities, including distributing masks and protective equipment during shortages[8]. - The group provides healthcare staffing solutions to over 20,000 qualified healthcare personnel in Hong Kong[142]. Corporate Governance - The company maintains high standards of corporate governance and transparency to protect the interests of shareholders[54]. - The board of directors held four meetings during the year, with all directors attending at least 75% of the meetings[67]. - The executive directors are responsible for daily management, while independent non-executive directors provide independent judgment on strategy and performance[55]. - The company has adhered to the corporate governance code as per the Hong Kong Stock Exchange regulations throughout the year[54]. - The board is responsible for major policy decisions, overall strategy, and significant transactions, ensuring robust internal controls and risk management[55]. - The company has established formal and transparent procedures for the selection and appointment of directors[89]. - The company has adopted a new corporate governance code based on the principles outlined in the listing rules, maintaining high standards of governance and transparency[108]. Risk Management and Internal Controls - The risk management system includes identifying risk categories, assessing their likelihood and impact, and evaluating the risk portfolio semi-annually[118]. - The internal control system is designed to ensure the effectiveness and reliability of financial reporting and operations[121]. - The board reviewed the adequacy and effectiveness of the risk management and internal control systems, finding no significant deficiencies[124]. Environmental, Social, and Governance (ESG) Initiatives - The group emphasizes sustainable development as an essential part of its business strategy to enhance long-term competitiveness[142]. - The board confirmed compliance with the Hong Kong Stock Exchange's ESG reporting guidelines during the reporting period[139]. - The company has established a dedicated Environmental, Social, and Governance (ESG) working group to oversee ESG procedures and risk management[155]. - The company aims to set strategic goals for the next three to five years to enhance its sustainability performance and stakeholder engagement[159]. - The company reported a reduction in nitrogen oxides (NOx) emissions from 1.56 kg in 2020 to 1.25 kg in 2021, representing a decrease of approximately 16%[164]. - The total greenhouse gas emissions decreased from 33.14 metric tons of CO2 equivalent in 2020 to 23.20 metric tons in 2021, a decline of approximately 30%[166]. Financial Management - The effective tax rate increased from approximately 15.2% to about 17.0%, with tax expenses rising to approximately HKD 12,500,000, a 127.1% increase from HKD 5,500,000 in the previous year[29]. - Trade receivables increased from approximately HKD 24,200,000 on June 30, 2020, to approximately HKD 65,500,000 on June 30, 2021, representing an increase of about 170%[33]. - Trade payables rose from approximately HKD 12,800,000 on June 30, 2020, to approximately HKD 22,700,000 on June 30, 2021, primarily due to increased costs for healthcare personnel[34]. - The group maintained cash and cash equivalents of approximately HKD 56,700,000, down from HKD 101,600,000 on June 30, 2020[36]. - The net current assets increased from approximately HKD 105,500,000 on June 30, 2020, to approximately HKD 127,200,000 on June 30, 2021[36]. Employee Management - The group employed a total of 72 employees as of June 30, 2021, down from 75 employees in 2020, with total employee costs amounting to approximately HKD 24,100,000[49]. - The company encourages employees to turn off electrical appliances when not in use to further reduce energy consumption[173].
百本医护(02293) - 2021 - 年度财报